| 22.11 -0.06 (-0.27%) | 07-31 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 27.55 | 1-year : | 32.18 |
| Resists | First : | 23.59 | Second : | 27.55 |
| Pivot price | 22.11  |
|||
| Supports | First : | 21.21 |
Second : | 19.75 |
| MAs | MA(5) : | 22.5 |
MA(20) : | 22.04 |
| MA(100) : | 19.26 |
MA(250) : | 21.71  |
|
| MACD | MACD : | 0.5 |
Signal : | 0.6 |
| %K %D | K(14,3) : | 58.7 |
D(3) : | 68.7 |
| RSI | RSI(14): 54 |
|||
| 52-week | High : | 32.31 | Low : | 16.6 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ USNA ] has closed above bottom band by 50.0%. Bollinger Bands are 21.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 22.33 - 22.47 | 22.47 - 22.57 |
| Low: | 21.34 - 21.52 | 21.52 - 21.65 |
| Close: | 21.87 - 22.14 | 22.14 - 22.34 |
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Sat, 01 Aug 2026
USANA Health Sciences, Inc. Revenue Breakdown – NYSE:USNA - TradingView
Fri, 31 Jul 2026
USANA Health Sciences Inc (USNA) Institutional Confidence - TradingKey
Thu, 30 Jul 2026
A 36-person, 12-week Glow trial reported brighter-looking, more even-toned skin - Stock Titan
Thu, 30 Jul 2026
New 12-Week Consumer Study Highlights Visible Skin Benefits with USANA Glow - Sahm
Tue, 28 Jul 2026
USANA Health Sciences Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Tue, 28 Jul 2026
How Usana Health Sciences Inc. (USNA) Affects Rotational Strategy Timing - Stock Traders Daily
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Household & Personal Products
|
|
| Shares Out | 18 (M) |
| Shares Float | 10 (M) |
| Held by Insiders | 40.8 (%) |
| Held by Institutions | 56.4 (%) |
| Shares Short | 753 (K) |
| Shares Short P.Month | 640 (K) |
| EPS | 0.5 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 29.45 |
| Profit Margin | 0.9 % |
| Operating Margin | 5.5 % |
| Return on Assets (ttm) | 4.1 % |
| Return on Equity (ttm) | 1.5 % |
| Qtrly Rev. Growth | 0.3 % |
| Gross Profit (p.s.) | 38.89 |
| Sales Per Share | 50.15 |
| EBITDA (p.s.) | 4.41 |
| Qtrly Earnings Growth | -16.7 % |
| Operating Cash Flow | 17 (M) |
| Levered Free Cash Flow | 30 (M) |
| PE Ratio | 44.22 |
| PEG Ratio | 0.8 |
| Price to Book value | 0.75 |
| Price to Sales | 0.44 |
| Price to Cash Flow | 24.54 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|